ARCHIVES

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

This article is from The Cancer Letter archive.

Vol. 06 No. 32 | August 8, 1980

Download PDF Visit The Full Archive

Related Articles

An Unusual Week Of Deals In Oncology: Alliances, Sales, and Dramatic Moves

November 13, 1998

Proposed Criteria For Establishing Carcinogenicity Listed

November 21, 1975

DCT Issues New Program Announcement On Clinical Research

December 5, 1980

Norris Cotton Cancer Center wins core grant renewal.

October 10, 2003

IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies

May 8, 1987

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014